Latest Cost Savings News

Regis Healthcare is set to acquire Royal Freemasons Homes of Victoria’s home care business, adding around 480 clients and lifting its annual home care revenue to approximately $50 million. The deal, funded from existing cash, awaits regulatory approval and is expected to close in the second quarter of FY27.

Advanced Innergy Holdings (ASX:AIH) has revised down its FY26 revenue and EBITDA forecasts due to project timing delays and supply chain issues but maintains a robust order book and financial position.

Neometals Ltd implements a significant 25% cut in cash personnel costs by reducing director and staff salaries, while introducing retention performance rights to key executives to maintain strategic momentum.

Spenda Limited has reshaped its business with significant cost cuts, divested non-core assets, and secured major shareholder backing, positioning itself for cash flow positive operations.

Nutritional Growth Solutions (ASX: NGS) has secured a $2.5 million placement and moved closer to acquiring Sprout Organic, aiming to boost revenue and cut costs amid improved cash flow.

Iondrive Limited has independently confirmed strong rare earth recoveries from U.S. magnet waste and gained Oklahoma government support for its first commercial processing module, advancing its U.S. commercialisation strategy.

Murray Cod Australia (ASX:MCA) reported a 53% jump in FY26 sales volumes and a 17.9% rise in customer receipts, underpinned by new retail deals with Coles and Woolworths and a focused cost-cutting program.

Galilee Energy has commenced drilling its Zydeco-1 well in Louisiana, executing a cost-optimised plan targeting up to 13.7 billion cubic feet of gas and 610,000 barrels of condensate, marking a key milestone in its US Gulf Coast expansion.

Anson Resources has dramatically expanded its Green River Lithium Project resource and confirmed robust project economics, while sealing a key agreement with POSCO for a demonstration plant funded by the Korean industrial giant.

Xenitra Limited (ASX:XEN) has turned around its cash flow in Q4 FY26, reporting positive operating cash flow of A$0.8 million driven by a leaner cost base and a shift towards higher-margin OTC medicines and blockchain-enabled OPAL tokenised sales.

Volt Group has delivered a record $5.1 million in half year revenue receipts for HY26, more than doubling prior year results, driven by strong contributions from its 4D Delta acquisition and solid performances across Wescone and EcoQuip.

Appen's Q2 FY26 results highlight a robust 26% revenue increase, driven by a 75% jump in its China segment and improving global operations. The company reiterates its full-year guidance amid ongoing AI market growth and operational efficiencies.